Search alternatives:
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1581
-
1582
-
1583
-
1584
-
1585
-
1586
-
1587
-
1588
-
1589
VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival.
Published 2018“…VRK1 score was determined by multiplying the VRK1 staining intensity × percentage of VRK1 positive staining. <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0203397#pone.0203397.g008" target="_blank">Fig 8A</a> includes the data from all primary tumor and lymph node samples. …”
-
1590
-
1591
-
1592
-
1593
-
1594
-
1595
-
1596
-
1597
-
1598
-
1599
-
1600
Mast cell density and tactile sensitivity decreased after 10 preventative imatinib treatments followed by repeated MI challenges.
Published 2020“…<p>For preventative imatinib treatment, mice were treated with 100 μL of 30 mg/kg imatinib dissolved in 0.9% saline injected intraperitoneally 30 minutes before each of 10 daily MI challenges. (A) Density of avidin<sup>+</sup> mast cells in 10 μm labiar skin cryo-sections from sensitized mice receiving NT or preventatively treated with imatinib and challenged 10 times daily with MI. …”